The Relationship Between Long-Term Glycemic Control and Partial Remission in Type 1 Diabetes: A Retrospective Study-Reference-Cited by-同舟云学术

The Relationship Between Long-Term Glycemic Control and Partial Remission in Type 1 Diabetes: A Retrospective Study

Published:2022-12-29 Issue:3 Volume:6 Page:252-259
ISSN:2587-0335
Container-title:Turkish Journal of Diabetes and Obesity
language:tr
Short-container-title:Turk J Diab Obes

Author:

CİMBEK Emine Ayça¹,BEKFİLAVİOĞLU Semiha²,KARAGÜZEL Gülay²

Affiliation:

1. KARADENİZ TEKNİK ÜNİVERSİTESİ, TIP FAKÜLTESİ

2. KARADENİZ TEKNİK ÜNİVERSİTESİ

Abstract

Aim: Partial remission (PR) is a significant period in the early course of type 1 diabetes (T1D) with implications for diabetes management. We aimed to investigate whether long-term hemoglobin A1c (HbA1c) outcomes in T1D differed as a result of experiencing PR. We also analyzed the demographic and clinical factors that may influence long-term glycemic control. Material and methods: We retrospectively tracked the HbA1c values of 131 children and adolescents with T1D over a 5-year period. Patients were stratified into low (

Publisher

Turkish Journal of Diabetes and Obesity

Subject

Microbiology

Reference45 articles.

1. 1. Giordano C, Amato MC, Ciresi A, Citarrella R, Mantione L, Accidenti M, et al. Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory. Eur J Intern Med [Internet]. 2011 Jun;22(3):266–74. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0953620511000409

2. 2. Pihoker C, Badaru A, Anderson A, Morgan T, Dolan L, Dabelea D, et al. Insulin Regimens and Clinical Outcomes in a Type 1 Diabetes Cohort. Diabetes Care [Internet]. 2013 Jan 1;36(1):27–33. Available from: https://diabetesjournals.org/care/article/36/1/27/38259/Insulin-Regimens-and-Clinical-Outcomes-in-a-Type-1

3. 3. Clements MA, Foster NC, Maahs DM, Schatz DA, Olson BA, Tsalikian E, et al. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry. Pediatr Diabetes [Internet]. 2016 Aug 1;17(5):327–36. Available from: https://onlinelibrary.wiley.com/doi/10.1111/pedi.12295

4. 4. Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA, et al. Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry. Diabetes Care [Internet]. 2015 Jun 1;38(6):971–8. Available from: https://diabetesjournals.org/care/article/38/6/971/37394/Current-State-of-Type-1-Diabetes-Treatment-in-the

5. 5. Steffes MW, Sibley S, Jackson M, Thomas W. β-Cell Function and the Development of Diabetes-Related Complications in the Diabetes Control and Complications Trial. Diabetes Care [Internet]. 2003 Mar 1;26(3):832–6. Available from: http://diabetesjournals.org/care/article-pdf/26/3/832/665500/dc0303000832.pdf